- Home
- REI vs SGHT Comparison
REI vs SGHT Comparison
Compare REI & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REI
- SGHT
- Stock Information
- Founded
- REI 2004
- SGHT 2011
- Country
- REI United States
- SGHT United States
- Employees
- REI N/A
- SGHT N/A
- Industry
- REI Oil & Gas Production
- SGHT Medical Specialities
- Sector
- REI Energy
- SGHT Health Care
- Exchange
- REI Nasdaq
- SGHT Nasdaq
- Market Cap
- REI 241.9M
- SGHT 209.9M
- IPO Year
- REI N/A
- SGHT 2021
- Fundamental
- Price
- REI $0.81
- SGHT $4.12
- Analyst Decision
- REI
- SGHT Buy
- Analyst Count
- REI 0
- SGHT 8
- Target Price
- REI N/A
- SGHT $4.01
- AVG Volume (30 Days)
- REI 4.3M
- SGHT 153.1K
- Earning Date
- REI 08-05-2025
- SGHT 07-31-2025
- Dividend Yield
- REI N/A
- SGHT N/A
- EPS Growth
- REI N/A
- SGHT N/A
- EPS
- REI 0.36
- SGHT N/A
- Revenue
- REI $335,642,768.00
- SGHT $78,109,000.00
- Revenue This Year
- REI $2.59
- SGHT N/A
- Revenue Next Year
- REI $17.45
- SGHT $11.60
- P/E Ratio
- REI $2.27
- SGHT N/A
- Revenue Growth
- REI N/A
- SGHT N/A
- 52 Week Low
- REI $0.72
- SGHT $2.03
- 52 Week High
- REI $2.06
- SGHT $8.45
- Technical
- Relative Strength Index (RSI)
- REI 47.63
- SGHT 64.03
- Support Level
- REI $0.81
- SGHT $3.99
- Resistance Level
- REI $0.94
- SGHT $4.25
- Average True Range (ATR)
- REI 0.06
- SGHT 0.21
- MACD
- REI 0.01
- SGHT -0.01
- Stochastic Oscillator
- REI 28.11
- SGHT 83.54
About REI Ring Energy Inc.
Ring Energy Inc is an independent exploration and production company based in The Woodlands, Texas and is engaged in oil and natural gas development, production, acquisition, and exploration activities currently focused in the Permian Basin of Texas. The drilling operations of the company target the oil and liquid rich producing formations in the Northwest Shelf, the Central Basin Platform and the Delaware Basin all of which are part of the Permian Basin in Texas.
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.